-
Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.
Wegiel B, Jiborn T, Abrahamson M, Helczynski L, Otterbein L, Persson JL, Bjartell A.
PLoS One. 2009 Nov 23; 4(11):e7953. Epub 2009 Nov 23.
[PLoS One. 2009]
-
Investigating Multi-cancer Biomarkers and Their Cross-predictability in the Expression Profiles of Multiple Cancer Types.
Tseng GC, Cheng C, Yu YP, Nelson J, Michalopoulos G, Luo JH.
Biomark Insights. 2009 May 1; 4:57-79. Epub 2009 May 1.
[Biomark Insights. 2009]
-
Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.
Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K, Miki J, Sasaki H, Hayashi N, Egawa S.
Am J Pathol. 2009 Jun; 174(6):2044-50. Epub 2009 May 12.
[Am J Pathol. 2009]
- » See all...